EN

Lincomicin 300

The first choice for superficial pyoderma treatment.

Antibiotic belonging to the group of Lincosamides. It is bacteriostatic, having an inhibitory action on bacterial protein synthesis, as it reversibly binds to the ribosomal 50s subunit of the bacteria, blocking the translocational movement of RNAm, and consequently the stretching of the polypeptide. Broad spectrum antibiotic for canine and feline

Indication

  • First choice for the treatment of superficial pyoderma
  • Prostate abscesses and abscesses in general
  • Osteomyelitis
  • Pneumonia
  • Pre and post surgical treatments (Digestive and trauma surgeries)
  • Infectious processes involving:
    • Gram-positive microorganisms: Staphylococcus (aureus, intermedius, beta-hemolytic), Streptococcus, Clostridium tetani, Clostridium swelchii.
    • Gram negative microorganisms: Escherichia coli, Bacillus (anthracis and cereus).
    • Mycoplasma, Actinomyces and some Nocardia.
    • Corynebacterium, Erysipelothrix and Campylobacter.

Dosage and administration

Oral administration.

To administer orally 1 tablet for each 20 kg of weight every 12 hours or at the indication of the Veterinarian. The duration of the treatment is variable, suggesting a minimum treatment of 7 and maximum of 30 days.

Formula

Each tablet contains:

Lincomycin (Monohydrate Hydrochloride) 300 mg, Excipient 500 mg.